The future of cardiac surgery depends on intrinsic innovative research, beyond retrospective or industry-driven studies to challenge the limits of cardiac surgery and to develop the patient care of tomorrow.
During the last decade we created an interdisciplinary research lab at the Department of Cardiac surgery with the vision to build a translational research group pursuing excellence in translational cardiovascular science following the best international examples.
Our research focuses on the understanding of pathomechanisms of cardiovascular disease in order to develop new treatment strategies. The strategy of our research lab is to find new treatment targets. Our research led to numerous patents and a close collaboration with not only some of the best researchers in Europe and the US, but also with the international Biotech and Medtech industry . Our efforts to realize translation led to the additional development of a clinical research team focusing on all aspects to conduct randomized controlled clinical trials , of which we today have several running in parallel at our department. This includes single-center as well as multi-center trials.
